3-2.jpg

NRG Oncology Virtual Summer Meeting

Join us for the NRG Oncology Virtual Summer Meeting July 16-18, 2020. Meeting Resources

NRG Oncology Virtual Summer Meeting

A Focus On Science

NRG Oncology and its partners have more than 150 years' experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and transnational biological studies that will be imperative for future clinical cancer research.


NCI Community Oncology Research Programs NCI National Clinical Trials Program

Uniquely positioned

Internationally recognized investigators populate the leadership and membership of all seven cancer disease site committees encompassed by NRG Oncology.

  • Brain tumors
  • Breast cancer
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Gynecologic cancer
  • Head and Neck cancer
  • Lung cancer
Learn More For Patients
NRG is a platform to find better treatment for cancer of tomorrow.

Patient Story

Clinical trials provide hope for
cancer fighters like me. Laurie

Our Mission

Improve the lives of cancer patients by conducting practice-changing multi-institutional clinical and translational research

Dr. Robert S. Mannel

Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.

Membership Resources

NRG Oncology's membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.

Learn More

Latest News

Card image cap
NRG Oncology Biospecimen Bank Awarded NCI Funding for Next 6 Years with ‘Exceptional’ Score

Read More
Card image cap
Trastuzumab Combined with Trimodality Treatment Does Not Improve Outcomes for Patients with HER2-Overexpressing Esophageal Cancer on NRG Oncology Trial

Read More
Card image cap
MTX-based Chemotherapy Combined with Low-Dose, Whole-Brain Radiotherapy Improves Progression-free Survival for Patients with Newly Diagnosed CNS Lymphoma

Read More

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.